CUL2
Basic information
Region (hg38): 10:35008504-35127006
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CUL2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 24 | 25 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 25 | 1 | 2 |
Variants in CUL2
This is a list of pathogenic ClinVar variants found in the CUL2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-35010318-A-G | not specified | Uncertain significance (Jun 29, 2023) | ||
10-35010333-T-C | not specified | Uncertain significance (May 11, 2022) | ||
10-35010339-G-A | not specified | Uncertain significance (Nov 27, 2023) | ||
10-35010357-A-G | Moyamoya angiopathy | Likely pathogenic (-) | ||
10-35010427-T-C | not specified | Uncertain significance (Apr 12, 2022) | ||
10-35011943-C-A | not specified | Uncertain significance (Apr 25, 2023) | ||
10-35016247-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
10-35016285-C-A | not specified | Uncertain significance (Feb 10, 2022) | ||
10-35028849-C-T | Benign (Apr 10, 2018) | |||
10-35028862-G-A | not specified | Uncertain significance (Feb 10, 2022) | ||
10-35031364-T-C | not specified | Uncertain significance (May 24, 2023) | ||
10-35031582-G-A | not specified | Uncertain significance (Jul 19, 2022) | ||
10-35035188-T-C | not specified | Uncertain significance (Jul 25, 2023) | ||
10-35035215-T-C | not specified | Uncertain significance (May 05, 2023) | ||
10-35035225-T-C | not specified | Uncertain significance (Aug 01, 2022) | ||
10-35035261-A-T | not specified | Uncertain significance (Jan 08, 2024) | ||
10-35038937-C-T | not specified | Uncertain significance (Dec 03, 2021) | ||
10-35039045-C-T | not specified | Uncertain significance (Mar 31, 2023) | ||
10-35044646-G-T | not specified | Uncertain significance (May 17, 2023) | ||
10-35044652-G-A | not specified | Uncertain significance (Apr 25, 2023) | ||
10-35044661-A-C | not specified | Uncertain significance (Dec 06, 2023) | ||
10-35044781-G-C | not specified | Uncertain significance (Mar 30, 2024) | ||
10-35044860-C-A | not specified | Uncertain significance (Aug 10, 2023) | ||
10-35044863-C-T | not specified | Uncertain significance (Apr 18, 2024) | ||
10-35049676-C-G | Benign (Apr 10, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CUL2 | protein_coding | protein_coding | ENST00000537177 | 21 | 82092 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 4.81e-8 | 125688 | 0 | 6 | 125694 | 0.0000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.25 | 217 | 400 | 0.542 | 0.0000211 | 5091 |
Missense in Polyphen | 42 | 122.83 | 0.34194 | 1704 | ||
Synonymous | 0.799 | 123 | 135 | 0.912 | 0.00000747 | 1283 |
Loss of Function | 6.49 | 1 | 51.0 | 0.0196 | 0.00000296 | 608 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000914 | 0.0000909 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000367 | 0.0000352 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Core component of multiple cullin-RING-based ECS (ElonginB/C-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complexes, which mediate the ubiquitination of target proteins. ECS complexes and ARIH1 collaborate in tandem to mediate ubiquitination of target proteins (PubMed:27565346). May serve as a rigid scaffold in the complex and may contribute to catalysis through positioning of the substrate and the ubiquitin-conjugating enzyme. The E3 ubiquitin-protein ligase activity of the complex is dependent on the neddylation of the cullin subunit and is inhibited by the association of the deneddylated cullin subunit with TIP120A/CAND1. The functional specificity of the ECS complex depends on the substrate recognition component. ECS(VHL) mediates the ubiquitination of hypoxia-inducible factor (HIF). {ECO:0000269|PubMed:10973499, ECO:0000269|PubMed:11384984, ECO:0000269|PubMed:27565346, ECO:0000269|PubMed:9122164}.;
- Pathway
- Renal cell carcinoma - Homo sapiens (human);HIF-1 signaling pathway - Homo sapiens (human);Ubiquitin mediated proteolysis - Homo sapiens (human);Pathways in cancer - Homo sapiens (human);Type 2 papillary renal cell carcinoma;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Regulation of Hypoxia-inducible Factor (HIF) by oxygen;Cellular response to hypoxia;Cellular responses to stress;Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Hypoxic and oxygen homeostasis regulation of HIF-1-alpha;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Cellular responses to external stimuli;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.194
Intolerance Scores
- loftool
- rvis_EVS
- -0.58
- rvis_percentile_EVS
- 18.59
Haploinsufficiency Scores
- pHI
- 0.724
- hipred
- Y
- hipred_score
- 0.739
- ghis
- 0.639
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.833
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cul2
- Phenotype
Zebrafish Information Network
- Gene name
- cul2
- Affected structure
- intersegmental vessel
- Phenotype tag
- abnormal
- Phenotype quality
- aplastic
Gene ontology
- Biological process
- G1/S transition of mitotic cell cycle;ubiquitin-dependent protein catabolic process;cell cycle arrest;negative regulation of cell population proliferation;viral process;protein ubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;regulation of transcription from RNA polymerase II promoter in response to hypoxia;intrinsic apoptotic signaling pathway
- Cellular component
- nucleoplasm;nucleolus;cytosol;SCF ubiquitin ligase complex;VCB complex;cullin-RING ubiquitin ligase complex;Cul2-RING ubiquitin ligase complex
- Molecular function
- protein binding;ubiquitin protein ligase binding;protein-containing complex binding;ubiquitin protein ligase activity